California Nanotechnologies Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA1304921010
CAD
0.35
0.32 (926.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a fall in PBT of -140128.29%, the company declared Very Negative results in May 25

  • The company has declared negative results in Nov 24 after 5 consecutive negative quarters
  • NET PROFIT(Q) At CAD -0.63 MM has Fallen at -2,109.31%
  • ROCE(HY) Lowest at -86.1%
  • PRE-TAX PROFIT(Q) Lowest at CAD -0.63 MM
2

Risky -

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 19 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-68.24%

stock-summary
Price to Book

5.71

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - May 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
900.0%
0%
900.0%
6 Months
1150.0%
0%
1150.0%
1 Year
1150.45%
0%
1150.45%
2 Years
759.95%
0%
759.95%
3 Years
288.89%
0%
288.89%
4 Years
548.15%
0%
548.15%
5 Years
400.0%
0%
400.0%

California Nanotechnologies Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
40.07%
EBIT Growth (5y)
-24.83%
EBIT to Interest (avg)
0.62
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
2.39
Tax Ratio
24.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
39.85%
ROE (avg)
25.88%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.78
EV to EBIT
-18.91
EV to EBITDA
18.91
EV to Capital Employed
5.66
EV to Sales
3.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-24.50%
ROE (Latest)
-68.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.00",
          "val2": "2.50",
          "chgp": "-60.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "1.00",
          "chgp": "-140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "0.20",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-590.30%",
          "val2": "337.60%",
          "chgp": "-92.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 91.11% vs 150.00% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is -140.00% vs 400.00% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "4.50",
          "chgp": "91.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.70",
          "val2": "1.10",
          "chgp": "145.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "-0.20",
          "chgp": "-750.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "0.50",
          "chgp": "-140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "222.00%",
          "val2": "190.30%",
          "chgp": "3.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - QoQstock-summary
May'25
Nov'24
Change(%)
Net Sales
1.00
2.50
-60.00%
Operating Profit (PBDIT) excl Other Income
-0.40
1.00
-140.00%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
0.30
-100.00%
Consolidate Net Profit
-0.60
0.20
-400.00%
Operating Profit Margin (Excl OI)
-590.30%
337.60%
-92.79%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Feb'25stock-summary
Feb'25
Feb'24
Change(%)
Net Sales
8.60
4.50
91.11%
Operating Profit (PBDIT) excl Other Income
2.70
1.10
145.45%
Interest
0.30
0.10
200.00%
Exceptional Items
-1.70
-0.20
-750.00%
Consolidate Net Profit
-0.20
0.50
-140.00%
Operating Profit Margin (Excl OI)
222.00%
190.30%
3.17%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2025 is 91.11% vs 150.00% in Feb 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2025 is -140.00% vs 400.00% in Feb 2024

stock-summaryCompany CV
About California Nanotechnologies Corp. stock-summary
stock-summary
California Nanotechnologies Corp.
Pharmaceuticals & Biotechnology
California Nanotechnologies Corp. is engaged in the development of nanocrystalline materials through grain size reduction. The Company focuses on commercialization efforts. It targets various markets, such as consumer electronics, aerospace, defense, automotive, oil and gas, medical, and sports and recreation. It supplies thermal spray powders that are utilized for wear, corrosion and thermal barrier coatings. Powders are available for plasma, high velocity oxygen fuel (HVOF) and particle tracking analysis (PTA) welding. Its Spark Plasma Sintering (SPS) allows for the application of temperature and pressure through high-density pulsed current within a controlled atmosphere. SPS applications include semiconductors, fine ceramics, thermoelectrics, electronics, nanophases, hard alloy tools, biomaterials, porous materials and molds and dies. To provide its products, the Company has an array of production facilities, including cold forging, cryogenic milling and spray drying.
Company Coordinates stock-summary
Company Details
17220 Edwards Rd , CERRITOS CA : 90703-2426
stock-summary
Tel: 1 562 9915211
stock-summary
Registrar Details